RaQualia Pharma Inc., July-September (3Q) Ordinary Profit Turns to Profit

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Thu Nov 14, 2024 3:30 pm JST Earnings

4579 RaQualia Pharma Inc. 【J-GAAP】

Earnings Report

RaQualia Pharma Inc. <4579> [TSE-G] announced its financial results after the market closed on November 14th (15:30). The consolidated ordinary loss for the cumulative third quarter of the fiscal year ending December 2024 (January to September) expanded to a loss of 231 million yen (compared to a loss of 36 million yen in the same period last year).

Based on the third-quarter cumulative performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the October to December period (4Q) is expected to turn into a profit of 521 million yen (compared to a loss of 257 million yen in the same period last year).

In the most recent three-month period, from July to September (3Q), the consolidated ordinary profit/loss turned to a profit of profit of 46 million yen (compared to a loss of 72 million yen in the same period last year). The operating profit/loss margin drastically improved from -17.7% in the same period last year to 13.3%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jan - Sep, 2022	1,904	501	676	467	22.3	74.8	Nov 11, 2022	J-GAAP
Jan - Sep, 2023	1,495	-108	-36	-117	-5.5	ー	Nov 10, 2023	J-GAAP
Jan - Sep, 2024	2,369	-27	-231	-339	-15.7	ー	Nov 14, 2024	J-GAAP
YoY	+58.5%	+75.0%	-541.7%	-189.7%	-188.3%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2023	887	-314	-329	-348	-16.1	0	Feb 14, 2024	J-GAAP
Jul - Dec, 2024 Guidance	3,124	467	567	559	25.6	0	Aug 14, 2024	J-GAAP
YoY	+252.2%	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2022	2,918	866	904	723	34.5	0	Feb 14, 2023	J-GAAP
Dec, 2023	1,901	-337	-293	-323	-15.0	0	Feb 14, 2024	J-GAAP
Dec, 2024 Guidance	4,535	313	290	236	10.8	0	Feb 14, 2024	J-GAAP
YoY	+138.6%	－	－	－	－

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	481	-85	-72	-142	-6.6	-17.7	Nov 10, 2023	J-GAAP
Oct - Dec, 2023	406	-229	-257	-206	-9.6	-56.4	Feb 14, 2024	J-GAAP
Jan - Mar, 2024	648	44	-77	-78	-3.6	6.8	May 15, 2024	J-GAAP
Apr - Jun, 2024	763	-198	-200	-245	-11.4	-26.0	Aug 14, 2024	J-GAAP
Jul - Sep, 2024	958	127	46	-16	-0.7	13.3	Nov 14, 2024	J-GAAP
YoY	+99.2%	－	－	+88.7%	+88.8%